DanCann Pharma A/S: Capital reduction completed
The capital reduction in DanCann Pharma A/S as resolved on an extraordinary general meeting held on 17 April 2024 has been completed today, 16 May 2024, following expiry of a 4-week notice period ("proklama").As set out in press release published on 17 April 2024, an extraordinary general meeting held on 17 April 2024 resolved to reduce the share capital of the Company by nominally DKK 4,582,269.6975 from nominally DKK 6,248,549.5875 to nominally DKK 1,666,279.89 by transfer of the amount to a special reserve fund (in Danish: henlæggelse til særlig reserve), cf. article 188(1)(3) of the